ATE154028T1 - Verfahren zur herstellung von azithromycin dihydrochloriden - Google Patents

Verfahren zur herstellung von azithromycin dihydrochloriden

Info

Publication number
ATE154028T1
ATE154028T1 AT95105285T AT95105285T ATE154028T1 AT E154028 T1 ATE154028 T1 AT E154028T1 AT 95105285 T AT95105285 T AT 95105285T AT 95105285 T AT95105285 T AT 95105285T AT E154028 T1 ATE154028 T1 AT E154028T1
Authority
AT
Austria
Prior art keywords
dihydrochlorides
azithromycin
producing
producing azithromycin
broad
Prior art date
Application number
AT95105285T
Other languages
English (en)
Inventor
Nevenka Lopotar
Stjepen Mutak
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Application granted granted Critical
Publication of ATE154028T1 publication Critical patent/ATE154028T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT95105285T 1994-04-15 1995-04-07 Verfahren zur herstellung von azithromycin dihydrochloriden ATE154028T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HR940251A HRP940251B1 (en) 1994-04-15 1994-04-15 Process for the preparation of azithromycin dihydrochloride

Publications (1)

Publication Number Publication Date
ATE154028T1 true ATE154028T1 (de) 1997-06-15

Family

ID=10946105

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95105285T ATE154028T1 (de) 1994-04-15 1995-04-07 Verfahren zur herstellung von azithromycin dihydrochloriden

Country Status (16)

Country Link
EP (1) EP0677530B1 (de)
JP (1) JP3075681B2 (de)
CN (1) CN1042033C (de)
AT (1) ATE154028T1 (de)
BG (1) BG61769B1 (de)
CA (1) CA2146475C (de)
DE (1) DE69500327T2 (de)
ES (1) ES2104441T3 (de)
HR (1) HRP940251B1 (de)
HU (1) HU217553B (de)
PL (1) PL177292B1 (de)
RO (1) RO113737B1 (de)
RU (1) RU2134271C1 (de)
SI (1) SI9500124A (de)
SK (1) SK281178B6 (de)
UA (1) UA41902C2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
KR100431431B1 (ko) * 2001-04-25 2004-05-14 한미약품 주식회사 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
EP1648473B1 (de) 2003-07-24 2009-01-28 PLIVA HRVATSKA d.o.o. Schnellösliches azithromycin in einzeldosisform
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
CN100343267C (zh) * 2005-08-05 2007-10-17 新昌国邦化学工业有限公司 阿奇霉素酒石酸盐的制备方法
CN100427499C (zh) * 2005-12-20 2008-10-22 山东诚创医药技术开发有限公司 一种阿奇霉素的可溶性盐及其制备方法
CN101092440B (zh) * 2007-07-19 2010-05-26 浙江尖峰药业有限公司 硫酸阿奇霉素的制备方法
CN102746350A (zh) * 2011-04-21 2012-10-24 常州泰康制药有限公司 盐酸阿奇霉素的制备方法
CN104045674B (zh) * 2014-05-21 2017-01-04 丽珠医药集团股份有限公司 一种阿奇霉素的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1100504A (en) * 1967-08-16 1968-01-24 Pliva Pharm & Chem Works Erythromycin oxime and 9-amino-3-o-cladinosyl-5-o-desosaminyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethylpentadecane-13-olide
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
SI8311553A8 (en) * 1983-07-18 1995-06-30 Pliva Pharm & Chem Works Process for preparing 7,16-dioxa-2-aza-10-0-cladynosil-12-0-desosaminyl-4,5-dihydroxy-6- ethyl-3,5,9,11,13,15-hexamethylbicyclo (11.2.1.) hexadeca-1(2)-ene-8-ones
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions

Also Published As

Publication number Publication date
CA2146475A1 (en) 1995-10-16
DE69500327T2 (de) 1998-01-08
HRP940251B1 (en) 1998-12-31
HU9501084D0 (en) 1995-06-28
HU217553B (hu) 2000-02-28
BG99580A (bg) 1995-12-29
BG61769B1 (bg) 1998-05-29
EP0677530B1 (de) 1997-06-04
ES2104441T3 (es) 1997-10-01
SK49195A3 (en) 1995-11-08
RU95105596A (ru) 1997-01-10
PL177292B1 (pl) 1999-10-29
SI9500124A (en) 1995-10-31
PL308095A1 (en) 1995-10-16
EP0677530A1 (de) 1995-10-18
CN1112566A (zh) 1995-11-29
HUT71840A (en) 1996-02-28
RO113737B1 (ro) 1998-10-30
JP3075681B2 (ja) 2000-08-14
CA2146475C (en) 1999-06-29
JPH0841058A (ja) 1996-02-13
SK281178B6 (sk) 2000-12-11
RU2134271C1 (ru) 1999-08-10
HRP940251A2 (en) 1997-06-30
CN1042033C (zh) 1999-02-10
UA41902C2 (uk) 2001-10-15
DE69500327D1 (de) 1997-07-10

Similar Documents

Publication Publication Date Title
DE59610116D1 (de) Verfahren zur Herstellung von D,L-Methionin oder dessen Alkalisalzen
DE69132355D1 (de) Verfahren zur Herstellung eines länglichen Glaskörpers
DE69611751D1 (de) Verfahren zur Herstellung von Zylinderblöcken
ATE154028T1 (de) Verfahren zur herstellung von azithromycin dihydrochloriden
MX9804046A (es) 6-0-metil eritromicina d y proceso para hacerla.
DE69023529D1 (de) Verfahren zur Behandlung von wässerigen Fermentationsbrühen.
DE69603766D1 (de) Verfahren zur Herstellung von Styren-Butadien-Kautschuk
AT379800B (de) Verfahren zur herstellung von neuen 2-oxazetidin-derivaten
DE69111301D1 (de) Verfahren zur Herstellung von Natriumchlorid.
DE69033871D1 (de) Arbeitsweise zur Herstellung doppelmodulus-orientierten Elastomerfilamente
DE69020172D1 (de) Verfahren zur Herstellung von epsilon-Caprolactam.
ATE128466T1 (de) Verfahren zur herstellung von 2,7- diazabicyclo(3.3.0)octanen.
ATE253583T1 (de) Verfahren zur herstellung von einem 3-cephem-4- carbonsäurederivat
DE59603826D1 (de) Verfahren zur kontinuierlichen Herstellung von macrocyclischen Verbindungen
DE69519253D1 (de) Verfahren zur Herstellung von plattenförmigem Bariumsulfat.
ATE181318T1 (de) Verfahren zur kontinuierlichen herstellung von wässrigen formaldehydlösungen
DE69519799D1 (de) Verfahren zur herstellung von [s,s]-ethylendiamin-n,n'-dibernsteinsäure
DE59403272D1 (de) Verfahren zur Herstellung Kautschukmischungen
DE68914362D1 (de) Impfstoff, geeignet zur Verhütung bzw. Kontrolle der durch Haemophilus pleuropneumoniae verursachte Schweinekrankheit und Verfahren zu dessen Herstellung.
DE59501060D1 (de) Verfahren zur Herstellung von 2,5-Dihydrofuran
DE59100382D1 (de) Verfahren zur Reinigung von wässerigen N-Methylmorpholin-N-oxid-Lösungen.
DE59608945D1 (de) Verfahren zur Herstellung von teilbaren Elastangarnen
DE69227490D1 (de) Verfahren zur Herstellung aktiver Kohlenstoffasern
DE59505557D1 (de) Verfahren zur Herstellung von Kautschukmischungen
DE59509651D1 (de) Verfahren zur Herstellung von 2,5-Dihydrofuran

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee